<html>
	<head>
		<title>analyst reiterates buy on some drug stocks</title>
		<meta name="keywords" content="places usa">
</head>
<body>
	<h3>merrill lynch and co analyst richard vietor said he reiterated a buy recommendation on several drug stocks today.     the stocks were bristol-myers co <bmy>, which rose 2-1/4 to 101, schering-plough corp <sgp> 2-7/8 to 97 and syntex corp <syn> 1-3/8 to 82. vietor described these stocks as a "middle group" of performers.     vietor said the prices of these stocks, "look pretty cheap relative to the leading performers in the drug group, such as upjohn co <upj>, merck and co inc <mrk>, and squibb corp <sqb>."     vietor said he also mentioned pfizer inc <pfe> up two to 72-3/4 and warner-lambert co <wla> up 1-1/2 to 74-1/2 as being in the middle group. but he did not recommend those stocks, which he rates as neutral.                                          reuter &#3;</h3>
</body>
</html>